Sun Pharma’s arm gets US FDA’s approval for diclofenac sodium topical solution: Report

09 Feb 2017 Evaluate

Taro Pharmaceutical Industries, the US subsidiary of Sun Pharmaceuticals Industries, has reportedly received tentative approval from the US Food and Drug Administration (US FDA) for diclofenac sodium topical solution of 2 per cent strength. Diclofenac sodium is indicated for mild to moderate pain, or signs and symptoms of osteoarthritis or rheumatoid arthritis.

Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

Sun Pharma Inds. Share Price

1806.90 20.65 (1.16%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×